Amphastar Pharmaceuticals Reports Q3 Revenue of $207.6 Million and GAAP EPS of $0. ...
Revenue of $207.6 Million and Adjusted EPS of $1.14 Both Beat Analyst Forecasts Related Stocks: AMPH ,
Revenue of $207.6 Million and Adjusted EPS of $1.14 Both Beat Analyst Forecasts Related Stocks: AMPH ,